Skip to content

VALIDATION OF THE PMD-200 SAFETY, PERFORMANCE AND CLINICAL UTILITY IN SUBJECTS REQUIRING SURGERY UNDER GENERAL ANESTHESIA

VALIDATION OF THE PMD-200 SAFETY, PERFORMANCE AND CLINICAL UTILITY IN SUBJECTS REQUIRING SURGERY UNDER GENERAL ANESTHESIA - Medasense-2 study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON43338
Enrollment
50
Registered
2016-07-21
Start date
2016-07-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

patienten onder anesthesie anesthesia pain

Interventions

Application pain stimuli prior to surgery
Nociception
Pain
Surgery

Sponsors

Medasense Bioemtrics
Lead Sponsor

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: Electie surgery Age 18+ ASA1-3

Exclusion criteria

Exclusion criteria: History of cardiac arrhythmia in the last 12 months Allergy to study medication neuromuscular disease alcohol or drug abuse beta-blocker use Use of morhine > 30 mg/day

Design outcomes

Primary

MeasureTime frame
NoL parameter

Secondary

MeasureTime frame
-

Countries

Canada

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)